Our group studies allosteric regulation mechanisms in protein kinases, ubiquitin ligases, and other signaling proteins. We use unique biophysical approaches to define key conformational changes that regulate signaling and how this regulation is disrupted in cancer. A second major focus of the lab is understanding how kinase inhibitors can trigger allosteric modulation of protein-protein interactions and kinase signaling functions in unanticipated ways.